Suppr超能文献

途径重连:经典途径和补体激活的凝集素途径的启动。

Paths reunited: Initiation of the classical and lectin pathways of complement activation.

机构信息

Department of Infection, Immunity and Inflammation, University of Leicester, UK.

出版信息

Immunobiology. 2010;215(1):1-11. doi: 10.1016/j.imbio.2009.08.006. Epub 2009 Sep 27.

Abstract

Understanding the structural organisation and mode of action of the initiating complex of the classical pathway of complement activation (C1) has been a central goal in complement biology since its isolation almost 50 years ago. Nevertheless, knowledge is still incomplete, especially with regard to the interactions between its subcomponents C1q, C1r and C1s that trigger activation upon binding to a microbial target. Recent studies have provided new insights into these interactions, and have revealed unexpected parallels with initiating complexes of the lectin pathway of complement: MBL-MASP and ficolin-MASP. Here, we develop and expand these concepts and delineate their implications towards the key aspects of complement activation via the classical and lectin pathways.

摘要

自 50 年前分离出经典补体激活途径起始复合物(C1)以来,了解其结构组织和作用模式一直是补体生物学的核心目标。然而,相关知识仍然不完整,特别是在其亚基 C1q、C1r 和 C1s 之间的相互作用方面,这些亚基在与微生物靶标结合时会引发激活。最近的研究为这些相互作用提供了新的见解,并揭示了与补体凝集素途径起始复合物(MBL-MASP 和 ficolin-MASP)之间出人意料的相似之处。在这里,我们发展和扩展了这些概念,并阐述了它们对经典和凝集素途径补体激活关键方面的影响。

相似文献

引用本文的文献

10
Complement system in Anti-CD20 mAb therapy for cancer: A mini-review.补体系统在抗 CD20 mAb 治疗癌症中的作用:小型综述。
Int J Immunopathol Pharmacol. 2023 Jan-Dec;37:3946320231181464. doi: 10.1177/03946320231181464.

本文引用的文献

7
Biological activities of C1 inhibitor.C1抑制剂的生物学活性。
Mol Immunol. 2008 Oct;45(16):4057-63. doi: 10.1016/j.molimm.2008.06.028. Epub 2008 Jul 31.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验